Cannabis Stocks Under $2: Why Are These Small-Cap Shares Up While Broader Sector Is In The Red?
Written by Emily J. Thompson, Senior Investment Analyst
Source: Business Insider
- Positive Performers Among Smaller Cannabis Stocks: Four lesser-valued cannabis stocks, including Medical Marijuana Inc., TILT Holdings, Trees Corp., and Village Farms International, showed positive performance despite the sector's downtrend.
- Operational Efficiency: Medical Marijuana Inc. and Trees Corp. demonstrate operational efficiency through their gross profit margins, indicating control over production costs and revenue generation capabilities.
- Comparison To Larger Cannabis Companies: The smaller stocks mentioned had modest gains compared to larger companies like Curaleaf Holdings, Canopy Growth, Trulieve Cannabis, and Green Thumb Industries, which experienced price decreases.
- Investors may find potential investment opportunities in these lesser-valued cannabis stocks due to their financial metrics, operational efficiencies, and ability to navigate a volatile market.
- Attendees can explore more about the cannabis business and investment opportunities at the 19th Benzinga Cannabis Capital Conference in Chicago on October 8-9, engaging with industry leaders and experts.
Analyst Views on CGC
Wall Street analysts forecast CGC stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for CGC is 3.78 USD with a low forecast of 1.80 USD and a high forecast of 5.76 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
3 Analyst Rating
1 Buy
2 Hold
0 Sell
Moderate Buy
Current: 1.170
Low
1.80
Averages
3.78
High
5.76
Current: 1.170
Low
1.80
Averages
3.78
High
5.76
About CGC
Canopy Growth Corporation is a Canada-based cannabis company. The principal activities of the Company are the production, distribution and sale of a diverse range of cannabis and cannabinoid-based products for both adult-use and medical purposes under a portfolio of distinct brands in Canada. The Company delivers innovative products from owned and licensed brands, including Tweed, 7ACRES, DOJA, Deep Space, and Claybourne, as well as category defining vaporization devices by Storz & Bickel. Its segments include Canada cannabis, and Storz & Bickel. Its Canada cannabis segment includes the production, distribution, and sale of a range of cannabis, hemp, and cannabis related products in Canada. Its Storz & Bickel segment includes the production, distribution, and sale of vaporizers. In addition, it serves medical cannabis patients globally with principal operations in Canada, Europe and Australia.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
